ArticleMolecular biology reports2025

Studying the cellular efficacy and tolerability of using CRISPR-gRNA ribonucleoprotein (RNP) complex for in-vitro knockdown of TRIB2 in acute myeloid leukaemia (AML) cells as preliminary clinical evaluations.

Josephine You Pheng Tan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.